SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-014678
Filing Date
2024-03-21
Accepted
2024-03-21 20:27:12
Documents
2
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1425
2 EXHIBIT 24 ef20024803_ex24.htm EX-24 8665
  Complete submission text file 0001140361-24-014678.txt   11716
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130
Business Address
Nussbaum Rodney L (Reporting) CIK: 0002014225 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 24772834